Managing Authorship

Related Articles Bringing Order to Authorship How to avoid disputes Establish who's who early on - When authorship disputes arise, young researchers are often in the most precarious situation. Markovitch advises that they push for meetings early in the process of research (long before the paper is written) to establish who will be considered the first author and the last author. If you work in a collaborative setting, this conversation may have to happen a few times. Stephen

Written byAndrea Gawrylewski
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Establish who's who early on - When authorship disputes arise, young researchers are often in the most precarious situation. Markovitch advises that they push for meetings early in the process of research (long before the paper is written) to establish who will be considered the first author and the last author. If you work in a collaborative setting, this conversation may have to happen a few times. Stephen Kimmel, director of cardiovascular epidemiology at the University of Pennsylvania, conducts a monthly conference call with all the PIs on a multidiscipline project; the only topic is author issues.

Encourage your group to include a contributions section in the paper - Nature strongly encourages its authors to list their contributions, but only about one-third of published papers have these credits, writes Linda Miller, executive editor of Nature, in an E-mail. A contribution section is "wonderful for interdisciplinary collaborations," says Scott Huettel at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies